Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 28, 2021 09:20 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy

RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned...
January 12, 2021 10:37 ET | Source: Asklepios BioPharmaceutical, Inc.

Gene Therapy Leader Katherine High Joins AskBio as President, Therapeutics

RESEARCH TRIANGLE PARK, N.C., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned...
December 11, 2020 09:07 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Named 2020 Business Person of the Year by Triangle Business Journal

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
November 19, 2020 08:00 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio and Selecta Biosciences Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia

RESEARCH TRIANGLE PARK, N.C. and WATERTOWN, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio) and Selecta Biosciences, Inc. (NASDAQ: SELB) today announced that the...
October 20, 2020 08:00 ET | Source: Asklepios BioPharmaceutical, Inc.

Selecta Biosciences and AskBio Receive FDA Rare Pediatric Disease Designation for their Gene Therapy for Methylmalonic Acidemia

WATERTOWN, Mass., and Research Triangle Park, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB) and Asklepios BioPharmaceutical, Inc. (AskBio), today announced the...
September 16, 2020 09:06 ET | Source: Asklepios BioPharmaceutical, Inc.

Kellie Sears Named AskBio Chief Human Resources Officer

RESEARCH TRIANGLE PARK, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
August 24, 2020 08:15 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Receives 2020 Life Sciences Award from the Triangle Business Journal

RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
August 06, 2020 08:00 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio Appoints Michael Kranda as SVP Therapeutic Practice Leader for Its Growing CNS Portfolio

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
August 03, 2020 09:30 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine

RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
July 23, 2020 09:19 ET | Source: Asklepios BioPharmaceutical, Inc.

Libbie Mansell Joins AskBio as SVP Regulatory Affairs

RESEARCH TRIANGLE PARK, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, announced...

Next Page keyboard_arrow_right